This article, which focuses on distribution and administration, is Part III of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets.
May 4, 2011
By:
Chan Harjivan, James Guyton
This article, which focuses on distribution and administration, is Part III of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets.
|
This article, which focuses on manufacturing and drug access, is Part II of a three-part series on biopharmaceutical issues in public health, government, and developing world markets.
Apr 6, 2011
By:
Chan Harjivan, Diana Elkis
This article, which focuses on manufacturing and drug access, is Part II of a three-part series on biopharmaceutical issues in public health, government, and developing world markets.
|
This article is Part I of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets. Part 1 focuses on drug development. Part II, which examines manufacturing, appears in the April 2011 of Sourcing and Management . Part III, which analyzes distribution and the supply chain, appears in the May 2011 issue.
Mar 2, 2011
By:
Chan Harjivan, George Dougherty
This article is Part I of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets. Part 1 focuses on drug-development. Part II, which examines manufacturing, appeared in the April 2011 of Sourcing and Management. Part III, which analyzes distribution and administration,appeared in the May 2011 issue.
|
|
